TNF and melanoma: Additionally, elevated circulating levels of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, and C-reactive protein (CRP), have been linked to increased melanoma progression and poorer clinical outcomes [22].